Single point mutations induce a switch in the molecular mechanism of the aggregation of the Alzheimer's disease associated Aβ42 peptide

ACS Chemical Biology

Volumn 9, Issue 2, 2014, Pages 378-382

  Bolognesi, Benedetta ^a,e   Cohen, Samuel I A ^a   Aran Terol, Pablo ^a   Esbjörner, Elin K ^a   Giorgetti, Sofia ^b   Mossuto, Maria F ^c   Natalello, Antonino ^d   Brorsson, Ann Christin ^a   Knowles, Tuomas P J ^a   Dobson, Christopher M ^a   Luheshi, Leila M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; ARTICLE; DROSOPHILA; MOLECULAR MECHANICS; NEUROTOXICITY; PATHOGENICITY; PHYSICAL CHEMISTRY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN STRUCTURE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; HUMANS; MICROSCOPY, ATOMIC FORCE; PEPTIDE FRAGMENTS; POINT MUTATION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84896689644     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400616y     Document Type: Article

References (27)

1. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75, 333-366
2. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., and Blake, C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction J. Mol. Biol. 273, 729-739
3. Knowles, T. P., Fitzpatrick, A. W., Meehan, S., Mott, H. R., Vendruscolo, M., Dobson, C. M., and Welland, M. E. (2007) Role of intermolecular forces in defining material properties of protein nanofibrils Science 318, 1900-1903
4. Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C. M. (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424, 805-808
5. Dubay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., and Vendruscolo, M. (2004) Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains J. Mol. Biol. 341, 1317-1326
6. De Strooper, B. (2010) Proteases and proteolysis in Alzheimer disease: A multifactorial view on the disease process Physiol. Rev. 90, 465-494
7. Luheshi, L. M., Tartaglia, G. G., Brorsson, A. C., Pawar, A. P., Watson, I. E., Chiti, F., Vendruscolo, M., Lomas, D. A., Dobson, C. M., and Crowther, D. C. (2007) Systematic in vivo analysis of the intrinsic determinants of amyloid β pathogenicity PLoS Biol. 5, 2493-2500
8. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. (2003) Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: Implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease J. Biol. Chem. 278, 46179-46187
9. Perálvarez-Marín, A., Mateos, L., Zhang, C., Singh, S., Cedazo-Mínguez, A., Visa, N., Morozova-Roche, L., Gräslund, A., and Barth, A. (2009) Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer's amyloid β peptide Biophys. J. 97, 277-285
10. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539
11. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid [β]-peptide Nat. Rev. Mol. Cell Biol. 8, 101-112
12. Ono, K., Condron, M. M., and Teplow, D. B. (2009) Structure-neurotoxicity relationships of amyloid β-protein oligomers Proc. Natl. Acad. Sci. U.S.A. 106, 14745-14750
13. 42 oligomers occurrs through secondary nucleation Proc. Natl. Acad. Sci. U.S.A. 110, 9758-9763
14. Nilsberth, C., Westlind-Danielsson, A., Eckman, C. B., Condron, M. M., Axelman, K., Forsell, C., Stenh, C., Luthman, J., Teplow, D. B., Younkin, S. G., Näslund, J., and Lannfelt, L. (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat. Neurosci. 4, 887-893
15. Johansson, A. S., Berglind-Dehlin, F., Karlsson, G., Edwards, K., Gellerfor, P., and Lannfelt, L. (2006) Physiochemical characterization of the Alzheimer's disease-related peptides A β 1-42 Arctic and A β 1-42wt FEBS J. 273, 2618-2630
16. Brorsson, A. C., Bolognesi, B., Tartaglia, G. G., Shammas, S. L., Favrin, G., Watson, I., Lomas, D. A., Chiti, F., Vendruscolo, M., Dobson, C. M., Crowther, D. C., and Luheshi, L. M. (2010) Intrinsic determinants of neurotoxic aggregate formation by the amyloid β peptide Biophys. J. 98, 1677-1684
17. Barth, A. (2007) Infrared spectroscopy of proteins Biochim. Biophys. Acta Bioenergy 1767, 1073-1101
18. Kodali, R., Williams, A. D., Chemuru, S., and Wetzel, R. (2010) Aβ(1-40) forms five distinct amyloid structures whose β-sheet contents and fibril stabilities are correlated J. Mol. Biol. 401, 503-517
19. Shammas, S. L., Knowles, T. P., Baldwin, A. J., Macphee, C. E., Welland, M. E., Dobson, C. M., and Devlin, G.L. (2011) Perturbation of the stability of amyloid fibrils through alteration of electrostatic interactions Biophys. J. 100, 2783-2791
20. Fandrich, M., Schmidt, M., and Grigorieff, N. (2011) Recent progress in understanding Alzheimer's β-amyloid structures Trends Biochem. Sci. 36, 338-345
21. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., and Tycko, R. (2002) A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl. Acad. Sci. 99, 16742-16747
22. Paravastu, A. K., Leapman, R. D., Yau, W. M., and Tycko, R. (2008) Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils Proc. Natl. Acad. Sci. U.S.A. 105, 18349-18354
23. Mossuto, M. F., Bolognesi, B., Guixer, B., Dhulesia, A., Agostini, F., Kumita, J. R., Tartaglia, G. G., Dumoulin, M., Dobson, C. M., and Salvatella, X. (2010) The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity J. Mol. Biol. 402, 783-96
24. Olofsson, A., Sauer-Eriksson, A. E., and Ohman, A. (2006) The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy J. Biol. Chem. 281, 477-483
25. Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., and Riek, R. (2005) 3D structure of Alzheimer's amyloid-β(1-42) fibrils Proc. Natl. Acad. Sci. U.S.A. 102, 17342-17347
26. Haupt, C., Morgado, I., Kumar, S. T., Parthier, C., Bereza, M., Hortschansky, P., Stubbs, M. T., Horn, U., and Fändrich, M. (2011) Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions J. Mol. Biol. 405, 341-348
27. Habicht, G., Christian Haupt, C., Friedrich, R. P., Hortschansky, P., Sachse, C., Meinhardt, J., Wieligmann, K., Gellermann, G. P., Brodhun, M., Götz, J., Halbhuber, K. J., Röcken, C., Horn, U., and Fändrich, M. (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrils Proc. Natl. Acad. Sci. U.S.A. 104, 19232-19237